- Home
- TCX vs ELDN Comparison
TCX vs ELDN Comparison
Compare TCX & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- ELDN
- Stock Information
- Founded
- TCX 1992
- ELDN 2004
- Country
- TCX Canada
- ELDN United States
- Employees
- TCX N/A
- ELDN N/A
- Industry
- TCX EDP Services
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- TCX Technology
- ELDN Health Care
- Exchange
- TCX Nasdaq
- ELDN Nasdaq
- Market Cap
- TCX 220.5M
- ELDN 202.4M
- IPO Year
- TCX 1996
- ELDN N/A
- Fundamental
- Price
- TCX $19.02
- ELDN $2.63
- Analyst Decision
- TCX
- ELDN Strong Buy
- Analyst Count
- TCX 0
- ELDN 2
- Target Price
- TCX N/A
- ELDN $12.50
- AVG Volume (30 Days)
- TCX 17.5K
- ELDN 1.0M
- Earning Date
- TCX 08-07-2025
- ELDN 08-14-2025
- Dividend Yield
- TCX N/A
- ELDN N/A
- EPS Growth
- TCX N/A
- ELDN N/A
- EPS
- TCX N/A
- ELDN 0.21
- Revenue
- TCX $378,467,000.00
- ELDN N/A
- Revenue This Year
- TCX N/A
- ELDN N/A
- Revenue Next Year
- TCX N/A
- ELDN N/A
- P/E Ratio
- TCX N/A
- ELDN $12.40
- Revenue Growth
- TCX 7.88
- ELDN N/A
- 52 Week Low
- TCX $13.27
- ELDN $2.38
- 52 Week High
- TCX $24.02
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- TCX 45.55
- ELDN 36.28
- Support Level
- TCX $19.58
- ELDN $2.54
- Resistance Level
- TCX $21.30
- ELDN $2.82
- Average True Range (ATR)
- TCX 1.15
- ELDN 0.21
- MACD
- TCX 0.08
- ELDN -0.08
- Stochastic Oscillator
- TCX 56.74
- ELDN 20.00
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.